Ode H - Search Results

1

A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis.

Ogawa S, Hachiya A, Hosaka M, Matsuda M, Ode H, Shigemi U, Okazaki R, Sadamasu K, Nagashima M, Toyokawa T, Tateyama M, Tanaka Y, Sugiura W, Yokomaku Y, Iwatani Y. Ogawa S, et al. Among authors: ode h. AIDS Res Hum Retroviruses. 2016 Mar;32(3):284-9. doi: 10.1089/AID.2015.0304. Epub 2015 Dec 1. AIDS Res Hum Retroviruses. 2016. PMID: 26528581

2

Computational simulations of HIV-1 proteases--multi-drug resistance due to nonactive site mutation L90M.

Ode H, Neya S, Hata M, Sugiura W, Hoshino T. Ode H, et al. J Am Chem Soc. 2006 Jun 21;128(24):7887-95. doi: 10.1021/ja060682b. J Am Chem Soc. 2006. PMID: 16771502

3

Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases.

Ode H, Ota M, Neya S, Hata M, Sugiura W, Hoshino T. Ode H, et al. J Phys Chem B. 2005 Jan 13;109(1):565-74. doi: 10.1021/jp046860+. J Phys Chem B. 2005. PMID: 16851048

4

Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations.

Ode H, Matsuyama S, Hata M, Hoshino T, Kakizawa J, Sugiura W. Ode H, et al. J Med Chem. 2007 Apr 19;50(8):1768-77. doi: 10.1021/jm061158i. Epub 2007 Mar 17. J Med Chem. 2007. PMID: 17367119

5

Computational characterization of structural role of the non-active site mutation M36I of human immunodeficiency virus type 1 protease.

Ode H, Matsuyama S, Hata M, Neya S, Kakizawa J, Sugiura W, Hoshino T. Ode H, et al. J Mol Biol. 2007 Jul 13;370(3):598-607. doi: 10.1016/j.jmb.2007.04.081. Epub 2007 May 10. J Mol Biol. 2007. PMID: 17524421

6

Structural and energetic analysis on the complexes of clinically isolated subtype C HIV-1 proteases and approved inhibitors by molecular dynamics simulation.

Matsuyama S, Aydan A, Ode H, Hata M, Sugiura W, Hoshino T. Matsuyama S, et al. Among authors: ode h. J Phys Chem B. 2010 Jan 14;114(1):521-30. doi: 10.1021/jp908314f. J Phys Chem B. 2010. PMID: 20055526

7

Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine.

Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H, Oka S. Gatanaga H, et al. Among authors: ode h. Antimicrob Agents Chemother. 2010 Apr;54(4):1596-602. doi: 10.1128/AAC.01480-09. Epub 2010 Feb 1. Antimicrob Agents Chemother. 2010. PMID: 20124001 Free PMC article.

8

Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.

Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H, Takiguchi M, Oka S. Gatanaga H, et al. Among authors: ode h. AIDS. 2010 Mar 13;24(5):F15-22. doi: 10.1097/QAD.0b013e328337b010. AIDS. 2010. PMID: 20160632

9

Within-host co-evolution of Gag P453L and protease D30N/N88D demonstrates virological advantage in a highly protease inhibitor-exposed HIV-1 case.

Shibata J, Sugiura W, Ode H, Iwatani Y, Sato H, Tsang H, Matsuda M, Hasegawa N, Ren F, Tanaka H. Shibata J, et al. Among authors: ode h. Antiviral Res. 2011 Apr;90(1):33-41. doi: 10.1016/j.antiviral.2011.02.004. Epub 2011 Feb 19. Antiviral Res. 2011. PMID: 21338625

10

Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.

Kitamura S, Ode H, Iwatani Y. Kitamura S, et al. Among authors: ode h. Front Microbiol. 2011 Dec 21;2:258. doi: 10.3389/fmicb.2011.00258. eCollection 2011. Front Microbiol. 2011. PMID: 22203821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters